Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 03, 2013

In re: ADDERALL XR ANTITRUST

Track this case

Case Number:

13-1232

Court:

Appellate - 2nd Circuit

Nature of Suit:

3410 STATUTES-Antitrust

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 09, 2014

    2nd Circ. Affirms Dismissal Of Adderall Pay-For-Delay Suit

    The Second Circuit on Monday found that Shire LLC didn't block generic competition for its attention-deficit-hyperactivity drug Adderall XR, saying a lower court was correct to dismiss a consolidated class action because Shire's patent licensing agreements didn't raise an antitrust issue.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login